Researchers provide more insight into treatment of severe asthma
La Jolla (California) , July 13 (ANI): Many individuals are unaware of how serious asthma may be. Asthma is thought to be the cause of ten American deaths each day, 439,000...
La Jolla (California) , July 13 (ANI): Many individuals are unaware of how serious asthma may be. Asthma is thought to be the cause of ten American deaths each day, 439,000...
Washington DC , July 12 (ANI): According to a new study published in JAMA Network Open, children who suffer racial discrimination are more likely to have a higher BMI and a...
Dunedin , July 12 (ANI): A University of Otago study demonstrates that a short plan of high intensity interval training before surgery can significantly aid recovery.The study, published in the...
Edmonton , July 12 (ANI): Researchers discovered a relationship between chemotherapy-induced changes in gut bacteria and the harmful weight gain seen in breast cancer patients, perhaps leading the way to...
Washington , July 11 (ANI): Scientists are focusing on how body weight can impact health outcomes as the obesity epidemic in the United States spreads. AYAs with acute lymphoblastic leukemia (ALL)...
Los Angeles (California) , July 11 (ANI): The condition of hypertension, which is a high blood pressure that can result in a heart attack or stroke, is managed by medication...
Washington DC , July 11 (ANI): According to new Stanford School of Medicine research, children with autism have memory issues that limit not only their ability to remember faces but...
Washington , July 11 (ANI): A case-control study published online in the journal Occupational & Environmental Medicine found that particular employment positions, such as hairdressers, beauticians, and accountants, may be...
Lausanne , July 11 (ANI): We utilise our motor learning abilities to teach ourselves how to run, pick up a drink, and walk so that we can get around in...
Cambridge , July 11 (ANI): Although most individuals don't associate oral disease with serious health issues, growing evidence suggests that oral bacteria play an important role in systemic disorders such...
La Jolla (California) [US], July 13 (ANI): Many individuals are unaware of how serious asthma may be. Asthma is thought to be the cause of ten American deaths each day, 439,000 hospital admissions per year, and 1.3 million visits to emergency rooms.
"Asthma is one of the most important allergic diseases to study," said Professor Toshiaki Kawakami, M.D., Ph.D., a member of the Center for Autoimmunity and Inflammation at La Jolla Institute for Immunology (LJI).
Kawakami and his LJI colleagues recently looked into the molecular causes of severe asthma and exacerbations of rhinovirus-induced asthma, a type of asthma that can occur along with a cold. Their research, which was just published in The Journal of Allergy and Clinical Immunology, suggests that individuals with both types of asthma may gain advantages from treatments that prevent interactions between a molecule known as histamine-releasing factor (HRF) and antibodies known as immunoglobulin E (IgE).
As Kawakami explains, many people with severe asthma aren't responsive to current asthma therapies. He hopes two potential drug strategies from his laboratory might inhibit HRF and IgE interactions and deliver relief for these patients. "We hope this approach can be a means of treating severe asthma and asthma exacerbation," he says.
Immune cells work as a team, and they secrete molecules to "talk" to each other. One of these molecular messengers is HRF, which is made by many types of cells, including lung epithelial cells and immune cells called macrophages. When a person encounters an allergen, these cells start churning out more HRF. The HRF then courses through the body and looks for special antibodies to bind to. HRF has several different kinds of antibody partners, however, and each interaction sends a different message to the surrounding immune cells.
Kawakami and his colleagues are working to understand how these HRF and antibody interactions drive dangerous allergic reactions. Over the last decade, the researchers have shown that HRF interactions with the IgE antibody drive harmful inflammation in mouse models of asthma.
Their new study is important because it sheds light on how this same HRF and IgE interaction triggers inflammation and drives asthma in humans. For the study, Kawakami collaborated with clinicians and scientists at the University of Pittsburgh School of Medicine; Children's Hospital, Boston; and the University of Virginia to investigate the role of HRF across many patient groups.
Working with this large range of patient samples was critical. "Asthma isn't just one disease," Kawakami says. There are different forms of asthma, called "endotypes," and current asthma therapies don't work for all patients. Truly understanding and treating asthma means gathering data from every patient group possible.
The team found that HRF and IgE interactions drive inflammation specifically in patients with severe asthma and patients with rhinovirus-induced asthma exacerbation. These findings in humans are in line with the lab's previous findings in mice.
The scientists further confirmed the importance of HRF and IgE interactions in laboratory experiments using a line of human bronchial cells. Kawakami and his colleagues observed a dramatic increase in HRF secretion when they infected these cells with rhinovirus. They saw the same dramatic increase when they exposed the bronchial cells to proteins from house dust mites (a very common allergen and asthma trigger).
Kawakami now hopes to test two potential asthma therapies. The first therapeutic approach would harness a molecule developed by the Kawakami Lab. This molecule, termed HRF-2CA, appears to inhibit asthma and severe food allergy symptoms in mice, and there's reason to think they could help treat humans as well. (ANI)